{
  "question_stem": {
    "en": "A 22-year-old woman is brought to the emergency department due to fever, headaches, nausea, and vomiting, and myalgias that began suddenly last night. This morning, the patient was lethargic, difficult to arouse, and confused. She is an exchange student who came to the United States 3 months ago, and her medical history is unknown. Temperature is 39.4 C (102.9 F), blood pressure is 100/60 mm Hg, pulse is 112/min, and respirations are 18/min. Physical examination shows nuchal rigidity. Skin examination findings are shown in the image. {{exhibit_1}} Leukocyte count is elevated, and lumbar puncture with cerebrospinal fluid Gram stain establishes the diagnosis.",
    "zh": "一名22岁女性因发烧、头痛、恶心、呕吐和肌痛被送至急诊科，这些症状突然始于昨晚。今天早上，患者嗜睡，难以唤醒，并且意识模糊。她是一名3个月前来到美国的交换生，病史不详。体温为39.4°C (102.9°F)，血压为100/60 mmHg，脉搏为112次/分钟，呼吸为18次/分钟。体格检查显示颈项强直。皮肤检查结果见图片。{{exhibit_1}} 白细胞计数升高，腰椎穿刺和脑脊液革兰染色确诊。"
  },
  "question": {
    "en": "Which of the following is most likely to be the primary antigenic component of the vaccine that could have prevented this patient's infection?",
    "zh": "以下哪项最可能是可预防该患者感染的疫苗的主要抗原成分？"
  },
  "options": {
    "A": {
      "en": "Capsular polysaccharide",
      "zh": "荚膜多糖"
    },
    "B": {
      "en": "Inactivated (killed) organisms",
      "zh": "灭活（灭活）病原体"
    },
    "C": {
      "en": "Inactivated toxic compounds",
      "zh": "灭活的毒性化合物"
    },
    "D": {
      "en": "Live attenuated organisms",
      "zh": "减毒活病原体"
    },
    "E": {
      "en": "Virus-like particles",
      "zh": "类病毒颗粒"
    }
  },
  "correct_answer": "A",
  "explanation": {
    "en": "This patient's rapid-onset headache, fever, altered mental status, nuchal rigidity, and purpuric rash (characteristic of meningococcemia) raise strong suspicion for MENINGOCOCCAL MENINGITIS. Neisseria meningitidis is a gram-negative diplococcus transmitted via aerosolized respiratory droplets. Close living conditions (eg, college dormitories, prisons, military barracks) promote its spread.\n\nN meningitidis has several virulence factors, including a polysaccharide capsule (impairs phagocytosis of the bacteria), lipo-oligosaccharide (induces cytokine production, leading to circulatory collapse), pili (permit bacterial attachment to the respiratory mucosa), and IgA protease (cleaves secretory IgA that would otherwise inactivate the pili). Antibodies against the POLYSACCHARIDE CAPSULE confer immunity to N meningitidis.\n\nThe meningococcal vaccines available in the United States are as follows:\n\nQuadrivalent conjugate vaccine: Capsular polysaccharide antigens (serogroups A, C, Y, and W) are fused to a diphtheria toxoid carrier, which allows the polysaccharides to be displayed on the major histocompatibility complex of antigen-presenting cells. This results in stimulation of T-cells and provides a stronger, more lasting immunologic response.\n\nSerogroup B vaccine: Capsular polysaccharides from serogroup B are very similar to human neural cell adhesion molecules. This molecular mimicry prevented a polysaccharide vaccine due to difficulty in generating an immune response without increasing the risk of autoimmunity. A vaccine against this serogroup is now available that uses recombinant proteins instead of capsular polysaccharides.\n\nIn the United States, the quadrivalent vaccine is part of routine immunizations; the serogroup B vaccine is recommended for specific high-risk populations (eg, those with asplenia or complement deficiency).\n\n(Choice B) The influenza vaccination typically contains three or four strains of inactivated virus. Although influenza is often associated with rapid-onset malaise, headache, myalgia, and fever, the presence of nuchal rigidity and purpuric skin rash make meningococcemia more likely.\n\n(Choice C) The diphtheria toxoid is used in conjugate vaccines because it allows the polysaccharide antigen to be displayed on the major histocompatibility complex of antigen-presenting cells. The toxoid is not the primary antigenic component of conjugate vaccines.\n\n(Choice D) The measles-mumps-rubella vaccination contains live attenuated versions of these viruses. Measles is associated with the 3 C's (coryza, conjunctivitis, cough) and a maculopapular rash, mumps is associated with salivary gland swelling, and rubella is associated with a diffuse maculopapular rash. A purpuric rash and nuchal rigidity would be atypical.\n\n(Choice E) Virus-like particles are multiprotein structures that elicit a strong B- and T-cell response but contain no viral genetic material, so they are not infectious. Virus-like particles are used in the hepatitis B and human papillomavirus vaccines.\n\nEducational objective:\nAntibodies against the polysaccharide capsule of Neisseria meningitidis provide immunity against this pathogen. Quadrivalent meningococcal vaccines contain capsular polysaccharides from major serotypes (A, C, Y, and W) of N meningitidis. Serotype B vaccinations use recombinant proteins.",
    "zh": "该患者的快速起病的头痛、发烧、精神状态改变、颈项强直和紫癜性皮疹（脑膜炎球菌血症的特征）高度提示脑膜炎奈瑟菌性脑膜炎。脑膜炎奈瑟菌是一种革兰氏阴性双球菌，通过雾化呼吸道飞沫传播。密切的生活条件（例如，大学宿舍、监狱、军营）促进其传播。\n\n脑膜炎奈瑟菌有几个毒力因子，包括荚膜多糖（损害细菌的吞噬作用）、脂寡糖（诱导细胞因子产生，导致循环衰竭）、菌毛（允许细菌附着在呼吸道黏膜上）和IgA蛋白酶（切割分泌性IgA，否则会使菌毛失活）。针对荚膜多糖的抗体可赋予对脑膜炎奈瑟菌的免疫力。\n\n美国可用的脑膜炎球菌疫苗如下：\n\n四价结合疫苗：荚膜多糖抗原（血清群A、C、Y和W）与白喉类毒素载体融合，这使得多糖能够在抗原呈递细胞的主要组织相容性复合物上显示。这导致T细胞的刺激，并提供更强、更持久的免疫反应。\n\nB群疫苗：B群荚膜多糖与人类神经细胞粘附分子非常相似。这种分子模拟阻止了多糖疫苗的使用，因为在不增加自身免疫风险的情况下难以产生免疫反应。现在可以使用针对该血清群的疫苗，该疫苗使用重组蛋白而不是荚膜多糖。\n\n在美国，四价疫苗是常规免疫接种的一部分；建议特定高危人群（例如，脾切除或补体缺陷者）接种B群疫苗。\n\n（选项B）流感疫苗通常包含三种或四种灭活病毒株。虽然流感通常与快速发作的不适、头痛、肌痛和发烧有关，但颈项强直和紫癜性皮疹的存在使脑膜炎球菌血症更有可能。\n\n（选项C）白喉类毒素用于结合疫苗中，因为它允许多糖抗原在抗原呈递细胞的主要组织相容性复合物上显示。类毒素不是结合疫苗的主要抗原成分。\n\n（选项D）麻疹-腮腺炎-风疹疫苗包含这些病毒的减毒活疫苗。麻疹与3个C（鼻炎、结膜炎、咳嗽）和斑丘疹有关，腮腺炎与唾液腺肿胀有关，风疹与弥漫性斑丘疹有关。紫癜性皮疹和颈项强直是不典型的。\n\n（选项E）类病毒颗粒是能引起强烈B细胞和T细胞反应的多蛋白结构，但不含病毒遗传物质，因此不具有传染性。类病毒颗粒用于乙型肝炎和人乳头瘤病毒疫苗。\n\n教育目标：\n针对脑膜炎奈瑟菌荚膜多糖的抗体可提供对该病原体的免疫力。四价脑膜炎球菌疫苗包含脑膜炎奈瑟菌主要血清型（A、C、Y和W）的荚膜多糖。B群疫苗使用重组蛋白。"
  },
  "summary": {
    "en": "This question tests the understanding of the antigenic components of vaccines used to prevent meningococcal meningitis, specifically focusing on the role of capsular polysaccharides in eliciting an immune response against Neisseria meningitidis.\n\nThe approach to solving this question involves recognizing the clinical presentation suggestive of meningococcal meningitis, recalling the primary virulence factor of Neisseria meningitidis (the polysaccharide capsule), and identifying which vaccine components target this virulence factor to provide immunity.",
    "zh": "此题考察对用于预防脑膜炎球菌性脑膜炎的疫苗的抗原成分的理解，特别是侧重于荚膜多糖在引发针对脑膜炎奈瑟菌的免疫反应中的作用。\n\n解决此问题的方法包括识别提示脑膜炎球菌性脑膜炎的临床表现，回忆脑膜炎奈瑟菌的主要毒力因子（荚膜多糖），并确定哪些疫苗成分靶向该毒力因子以提供免疫力。"
  },
  "tags": "Meningococcal meningitis; Neisseria meningitidis; Vaccine; Capsular polysaccharide; Conjugate vaccine; Gram-negative diplococcus; Virulence factors; Public health; Infectious disease",
  "category": "Neuro",
  "question_id": "1853",
  "has_exhibits": true,
  "exhibit_count": 3,
  "exhibit_files": [
    "image1.jpg",
    "image2.jpg",
    "image3.jpg"
  ],
  "folder_path": "C:\\Datas\\usmle\\step1\\clip\\Neuro 24\\1853",
  "extracted_at": "2025-11-05T19:37:05.869357",
  "extraction_config": {
    "temperature": 0.1,
    "top_k": 2,
    "prompt_strategy": "standard"
  },
  "translated_at": "2025-11-07T18:36:20.493938",
  "translation_model": "gemini-2.0-flash-lite",
  "embedding_model": "models/embedding-001",
  "embedding_dimension": 768
}